HGF and neoplasm: Several studies have reported molecular alterations in the system comprising hepatocyte growth factor (HGF) and its tyrosine kinase receptor MET (HGF/MET system) in different types of neoplasias [3, 4], in which inappropriate MET activation enhances proliferation, anti-apoptotic events, invasiveness and metastatization [5, 6].